Company Secretary to be relieved from duties on June 10, 2026

Kmp ResignedManagement Changes View source PDF Explain this filing

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.2%Reaction day

₹1122.00

prior close

₹1126.20

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.1%+6.3% vs market

Pharmaceuticals peers, median of 165sector-0.6%+5.8% vs sector

On the reaction day the stock moved 6.3 pts more than Nifty Microcap 250 and 5.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.0

10m

+2.0

15m

+3.2

30m

+3.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.2-1.1+6.3-0.6+5.8

Next day

+15.1+1.9+13.2+0.5+14.5

+14.0+3.7+10.4+0.9+13.2

+12.3+4.2+8.1+0.8+11.5

+12.8+5.4+7.5+1.0+11.9

+17.0+5.9+11.1+1.8+15.2

+15.2+7.6+7.6+2.5+12.7

15d

+23.8+7.7+16.1+6.1+17.7

+27.8+8.6+19.2+5.2+22.6

+32.2+10.5+21.7+6.3+25.9

+31.1+13.3+17.7+9.6+21.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vinay Kumar Mishra, who had resigned earlier as Company Secretary and Compliance Officer (intimation dated May 14, 2026), will be relieved from duties at close of business on June 10, 2026. Managing Director Swapnil Shah and Whole Time Director and CFO Deval Shah have been designated as authorised Key Managerial Personnel for determining materiality of events under SEBI Listing Regulations.

Likely market impact

Company Secretary is a key compliance role; investors should watch for a timely replacement appointment to ensure regulatory continuity.